ARS Pharmaceuticals, Inc. Common Stock SPRY
$5.62
-0.88%
at last close
Financials (TTM)
- Revenue
- $116.93 million
- Net Income
- $-215,432,000
- Net Margin
- -184.24%
- Return on Equity
- -1721.80%
- Debt-to-Equity
- 7.73
- P/E Ratio
- —
- Price / Book
- 44.67
- Price / Sales
- 4.78
Over the trailing twelve months, ARS Pharmaceuticals, Inc. Common Stock generated revenue of $116.93 million and net income of $-215,432,000, a net margin of -184.24%.
At the last closing price of $5.62, SPRY trades at 4.78 times sales, with a market capitalization of $558.89 million.
Key Stats
- Last Close
- $5.62
- Market Cap
- $558.89 million
- 52-Week Range
- $4.91 – $18.00
- Average Volume
- 1.90 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.